microRNA information: hsa-miR-744-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-744-3p | miRbase |
| Accession: | MIMAT0004946 | miRbase |
| Precursor name: | hsa-mir-744 | miRbase |
| Precursor accession: | MI0005559 | miRbase |
| Symbol: | MIR744 | HGNC |
| RefSeq ID: | NR_030613 | GenBank |
| Sequence: | CUGUUGCCACUAACCUCAACCU |
Reported expression in cancers: hsa-miR-744-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-744-3p | breast cancer | upregulation | "The aim of this study was to investigate the role ......" | 27746365 | qPCR |
| hsa-miR-744-3p | head and neck cancer | deregulation | "A global miRNA profiling was performed on 12 sampl ......" | 21637912 | qPCR; Microarray |
| hsa-miR-744-3p | liver cancer | downregulation | "Increasing evidences indicate that miR-744 deregul ......" | 24991193 | |
| hsa-miR-744-3p | pancreatic cancer | upregulation | "MiR 744 increases tumorigenicity of pancreatic can ......" | 26485754 |
Reported cancer pathway affected by hsa-miR-744-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-744-3p | cervical and endocervical cancer | cell cycle pathway; Apoptosis pathway | "These include hsa-miR-138 hsa-miR-210 and hsa-miR- ......" | 23012319 | |
| hsa-miR-744-3p | cervical and endocervical cancer | Apoptosis pathway | "MicroRNA 744 inhibited cervical cancer growth and ......" | 27261616 | |
| hsa-miR-744-3p | liver cancer | cell cycle pathway | "Decrease expression of microRNA 744 promotes cell ......" | 24991193 | Luciferase; Western blot |
Reported cancer prognosis affected by hsa-miR-744-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-744-3p | breast cancer | worse prognosis; drug resistance | "The aim of this study was to investigate the role ......" | 27746365 | |
| hsa-miR-744-3p | cervical and endocervical cancer | progression | "These include hsa-miR-138 hsa-miR-210 and hsa-miR- ......" | 23012319 | |
| hsa-miR-744-3p | cervical and endocervical cancer | progression; metastasis | "MicroRNA 744 inhibited cervical cancer growth and ......" | 27261616 | |
| hsa-miR-744-3p | head and neck cancer | malignant trasformation | "A global miRNA profiling was performed on 12 sampl ......" | 21637912 | |
| hsa-miR-744-3p | liver cancer | poor survival; recurrence; worse prognosis | "miR 744 is a potential prognostic marker in patien ......" | 25543521 | |
| hsa-miR-744-3p | pancreatic cancer | poor survival | "MiR 744 increases tumorigenicity of pancreatic can ......" | 26485754 | |
| hsa-miR-744-3p | pancreatic cancer | metastasis; recurrence; progression; poor survival; drug resistance; worse prognosis | "Plasma microRNA profiles: identification of miR 74 ......" | 26505678 |
Reported gene related to hsa-miR-744-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-744-3p | cervical and endocervical cancer | BCL2 | "MicroRNA 744 inhibited cervical cancer growth and ......" | 27261616 |
| hsa-miR-744-3p | cervical and endocervical cancer | CASP3 | "In addition both up-regulation of miR-744 and down ......" | 27261616 |
| hsa-miR-744-3p | prostate cancer | INSR | "Two of the most potent IR sensitizing miRNAs miR-8 ......" | 25845598 |
| hsa-miR-744-3p | liver cancer | MYC | "Decrease expression of microRNA 744 promotes cell ......" | 24991193 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-744-3p | CCR2 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.549; TCGA CESC -0.413; TCGA COAD -0.241; TCGA ESCA -0.678; TCGA HNSC -0.452; TCGA LGG -0.221; TCGA LUAD -0.12; TCGA LUSC -0.461; TCGA OV -0.171; TCGA PRAD -0.277; TCGA SARC -0.543; TCGA THCA -0.546; TCGA UCEC -0.296 |
hsa-miR-744-3p | HLF | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.779; TCGA BRCA -0.203; TCGA CESC -0.294; TCGA COAD -0.361; TCGA HNSC -0.245; TCGA LUAD -0.505; TCGA LUSC -0.203; TCGA OV -0.145; TCGA PRAD -0.426; TCGA SARC -0.411; TCGA STAD -0.677; TCGA UCEC -0.597 |
hsa-miR-744-3p | TXLNB | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.498; TCGA CESC -0.271; TCGA COAD -0.459; TCGA ESCA -0.321; TCGA HNSC -0.498; TCGA LUSC -0.166; TCGA SARC -0.155; TCGA THCA -0.755; TCGA STAD -0.437; TCGA UCEC -0.557 |
hsa-miR-744-3p | SELE | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.449; TCGA CESC -0.295; TCGA COAD -0.437; TCGA ESCA -0.377; TCGA HNSC -0.283; TCGA LUAD -0.176; TCGA LUSC -0.576; TCGA PRAD -0.64; TCGA SARC -0.21; TCGA THCA -0.599; TCGA UCEC -0.495 |
hsa-miR-744-3p | TMOD1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.325; TCGA BRCA -0.097; TCGA COAD -0.307; TCGA ESCA -0.388; TCGA HNSC -0.332; TCGA KIRP -0.404; TCGA LGG -0.106; TCGA LUAD -0.134; TCGA LUSC -0.198; TCGA OV -0.165; TCGA PRAD -0.207; TCGA SARC -0.433; TCGA STAD -0.341; TCGA UCEC -0.334 |
hsa-miR-744-3p | CCDC69 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.428; TCGA BRCA -0.175; TCGA CESC -0.253; TCGA COAD -0.431; TCGA ESCA -0.468; TCGA HNSC -0.306; TCGA LUAD -0.205; TCGA LUSC -0.455; TCGA PRAD -0.409; TCGA SARC -0.458; TCGA THCA -0.273; TCGA STAD -0.464; TCGA UCEC -0.424 |
hsa-miR-744-3p | PTPN5 | 9 cancers: BLCA; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.46; TCGA ESCA -0.648; TCGA HNSC -0.48; TCGA LUAD -0.242; TCGA LUSC -0.417; TCGA PRAD -0.301; TCGA THCA -0.535; TCGA STAD -0.53; TCGA UCEC -0.335 |
hsa-miR-744-3p | ITGBL1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.525; TCGA BRCA -0.128; TCGA COAD -0.542; TCGA ESCA -0.559; TCGA HNSC -0.216; TCGA LIHC -0.302; TCGA LUAD -0.101; TCGA LUSC -0.347; TCGA OV -0.236; TCGA PAAD -0.3; TCGA THCA -0.619; TCGA STAD -0.281; TCGA UCEC -0.327 |
hsa-miR-744-3p | RHOB | 13 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.163; TCGA BRCA -0.238; TCGA COAD -0.177; TCGA ESCA -0.119; TCGA LGG -0.088; TCGA LUAD -0.137; TCGA LUSC -0.236; TCGA PAAD -0.209; TCGA PRAD -0.334; TCGA SARC -0.239; TCGA THCA -0.158; TCGA STAD -0.31; TCGA UCEC -0.187 |
hsa-miR-744-3p | SSPN | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.341; TCGA CESC -0.221; TCGA COAD -0.555; TCGA ESCA -0.309; TCGA HNSC -0.285; TCGA LGG -0.072; TCGA LUAD -0.14; TCGA LUSC -0.23; TCGA PRAD -0.418; TCGA SARC -0.184; TCGA STAD -0.431; TCGA UCEC -0.344 |
hsa-miR-744-3p | KIAA0430 | 10 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.076; TCGA CESC -0.094; TCGA COAD -0.084; TCGA ESCA -0.119; TCGA LIHC -0.063; TCGA LUAD -0.095; TCGA LUSC -0.062; TCGA SARC -0.089; TCGA STAD -0.165; TCGA UCEC -0.128 |
hsa-miR-744-3p | TMEM140 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.175; TCGA CESC -0.188; TCGA COAD -0.2; TCGA ESCA -0.075; TCGA HNSC -0.194; TCGA LIHC -0.076; TCGA LUAD -0.057; TCGA LUSC -0.187; TCGA PRAD -0.068; TCGA SARC -0.226; TCGA THCA -0.218; TCGA UCEC -0.168 |
hsa-miR-744-3p | DIP2C | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.108; TCGA CESC -0.082; TCGA COAD -0.267; TCGA ESCA -0.14; TCGA HNSC -0.071; TCGA LIHC -0.141; TCGA SARC -0.132; TCGA STAD -0.308; TCGA UCEC -0.093 |
hsa-miR-744-3p | CD1D | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.308; TCGA BRCA -0.149; TCGA CESC -0.133; TCGA COAD -0.28; TCGA ESCA -0.536; TCGA HNSC -0.152; TCGA KIRC -0.199; TCGA LGG -0.334; TCGA LUAD -0.088; TCGA LUSC -0.288; TCGA PRAD -0.314; TCGA STAD -0.132; TCGA UCEC -0.169 |
hsa-miR-744-3p | SIGLEC10 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PRAD; THCA | MirTarget | TCGA BLCA -0.456; TCGA CESC -0.212; TCGA COAD -0.222; TCGA ESCA -0.291; TCGA HNSC -0.399; TCGA LUSC -0.303; TCGA OV -0.15; TCGA PRAD -0.246; TCGA THCA -0.445 |
hsa-miR-744-3p | C5AR1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PRAD; THCA | MirTarget | TCGA BLCA -0.398; TCGA CESC -0.175; TCGA COAD -0.272; TCGA ESCA -0.192; TCGA HNSC -0.152; TCGA LGG -0.114; TCGA LUAD -0.113; TCGA LUSC -0.442; TCGA PRAD -0.104; TCGA THCA -0.4 |
hsa-miR-744-3p | MEF2C | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.372; TCGA CESC -0.176; TCGA COAD -0.344; TCGA ESCA -0.356; TCGA HNSC -0.373; TCGA LIHC -0.128; TCGA LUAD -0.181; TCGA LUSC -0.358; TCGA PRAD -0.283; TCGA SARC -0.124; TCGA STAD -0.355; TCGA UCEC -0.449 |
hsa-miR-744-3p | ADAMTSL3 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.716; TCGA COAD -0.754; TCGA ESCA -0.56; TCGA HNSC -0.317; TCGA KIRP -0.301; TCGA LIHC -0.249; TCGA LUAD -0.304; TCGA LUSC -0.405; TCGA OV -0.182; TCGA PRAD -0.431; TCGA STAD -0.524; TCGA UCEC -0.377 |
hsa-miR-744-3p | CAV2 | 9 cancers: BLCA; COAD; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.206; TCGA COAD -0.307; TCGA LUAD -0.221; TCGA LUSC -0.25; TCGA PAAD -0.32; TCGA PRAD -0.495; TCGA SARC -0.121; TCGA STAD -0.257; TCGA UCEC -0.406 |
hsa-miR-744-3p | SCN2B | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.652; TCGA BRCA -0.414; TCGA COAD -0.813; TCGA ESCA -0.366; TCGA HNSC -0.27; TCGA KIRP -0.391; TCGA LUAD -0.362; TCGA LUSC -0.442; TCGA OV -0.166; TCGA PRAD -0.568; TCGA SARC -0.45; TCGA STAD -0.691; TCGA UCEC -0.447 |
hsa-miR-744-3p | BOC | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.59; TCGA BRCA -0.127; TCGA COAD -0.648; TCGA ESCA -0.396; TCGA HNSC -0.189; TCGA KIRP -0.332; TCGA LGG -0.183; TCGA LIHC -0.276; TCGA PRAD -0.286; TCGA STAD -0.535; TCGA UCEC -0.261 |
hsa-miR-744-3p | CASP10 | 11 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.142; TCGA CESC -0.389; TCGA ESCA -0.352; TCGA HNSC -0.146; TCGA LUAD -0.132; TCGA LUSC -0.248; TCGA PAAD -0.344; TCGA PRAD -0.243; TCGA SARC -0.102; TCGA THCA -0.115; TCGA UCEC -0.289 |
hsa-miR-744-3p | H6PD | 10 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.071; TCGA CESC -0.132; TCGA ESCA -0.106; TCGA HNSC -0.061; TCGA LIHC -0.089; TCGA LUAD -0.056; TCGA PAAD -0.105; TCGA PRAD -0.055; TCGA STAD -0.089; TCGA UCEC -0.096 |
hsa-miR-744-3p | VIPR2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.758; TCGA BRCA -0.377; TCGA CESC -0.507; TCGA COAD -0.694; TCGA ESCA -0.757; TCGA HNSC -0.485; TCGA LGG -0.187; TCGA LUSC -0.355; TCGA OV -0.219; TCGA PRAD -0.535; TCGA SARC -0.601; TCGA STAD -0.678; TCGA UCEC -0.474 |
hsa-miR-744-3p | DUSP22 | 10 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.144; TCGA CESC -0.098; TCGA HNSC -0.097; TCGA KIRP -0.065; TCGA LUAD -0.05; TCGA LUSC -0.167; TCGA PAAD -0.087; TCGA SARC -0.099; TCGA STAD -0.12; TCGA UCEC -0.136 |
hsa-miR-744-3p | PDLIM2 | 10 cancers: BLCA; BRCA; COAD; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | mirMAP | TCGA BLCA -0.247; TCGA BRCA -0.186; TCGA COAD -0.159; TCGA LGG -0.08; TCGA LUAD -0.202; TCGA LUSC -0.306; TCGA PAAD -0.161; TCGA PRAD -0.128; TCGA SARC -0.084; TCGA THCA -0.262 |
hsa-miR-744-3p | WDFY4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.598; TCGA BRCA -0.072; TCGA CESC -0.321; TCGA COAD -0.338; TCGA ESCA -0.562; TCGA HNSC -0.398; TCGA LUAD -0.183; TCGA LUSC -0.501; TCGA PAAD -0.319; TCGA PRAD -0.237; TCGA SARC -0.212; TCGA THCA -0.536; TCGA UCEC -0.104 |
hsa-miR-744-3p | NTRK3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.678; TCGA BRCA -0.137; TCGA CESC -0.248; TCGA COAD -0.72; TCGA ESCA -0.761; TCGA HNSC -0.382; TCGA LUAD -0.34; TCGA LUSC -0.481; TCGA PRAD -0.498; TCGA SARC -0.336; TCGA STAD -0.594; TCGA UCEC -0.465 |
hsa-miR-744-3p | PIP4K2A | 9 cancers: BLCA; COAD; ESCA; HNSC; LUSC; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.193; TCGA COAD -0.16; TCGA ESCA -0.184; TCGA HNSC -0.057; TCGA LUSC -0.14; TCGA PAAD -0.155; TCGA SARC -0.069; TCGA THCA -0.141; TCGA STAD -0.146 |
hsa-miR-744-3p | PLXDC1 | 13 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.157; TCGA BRCA -0.107; TCGA CESC -0.174; TCGA COAD -0.19; TCGA KIRC -0.296; TCGA KIRP -0.149; TCGA LIHC -0.329; TCGA LUAD -0.105; TCGA LUSC -0.157; TCGA PRAD -0.096; TCGA THCA -0.213; TCGA STAD -0.11; TCGA UCEC -0.251 |
hsa-miR-744-3p | IL16 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.43; TCGA BRCA -0.111; TCGA CESC -0.356; TCGA COAD -0.208; TCGA ESCA -0.258; TCGA HNSC -0.271; TCGA LUAD -0.166; TCGA LUSC -0.409; TCGA OV -0.101; TCGA PAAD -0.254; TCGA PRAD -0.214; TCGA SARC -0.255; TCGA THCA -0.505; TCGA STAD -0.152; TCGA UCEC -0.261 |
hsa-miR-744-3p | CIITA | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.357; TCGA BRCA -0.116; TCGA CESC -0.459; TCGA ESCA -0.425; TCGA HNSC -0.476; TCGA LIHC -0.129; TCGA LUAD -0.165; TCGA LUSC -0.494; TCGA OV -0.145; TCGA PAAD -0.454; TCGA PRAD -0.234; TCGA SARC -0.401; TCGA THCA -0.443; TCGA UCEC -0.214 |
hsa-miR-744-3p | PRELP | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.853; TCGA BRCA -0.168; TCGA CESC -0.244; TCGA COAD -0.922; TCGA ESCA -0.597; TCGA HNSC -0.454; TCGA LUAD -0.23; TCGA LUSC -0.503; TCGA OV -0.188; TCGA PAAD -0.38; TCGA PRAD -0.356; TCGA SARC -0.764; TCGA THCA -0.729; TCGA STAD -0.625; TCGA UCEC -0.627 |
hsa-miR-744-3p | PTPRT | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.283; TCGA BRCA -0.356; TCGA COAD -0.491; TCGA ESCA -0.385; TCGA LUAD -0.394; TCGA LUSC -0.321; TCGA SARC -0.431; TCGA STAD -0.335; TCGA UCEC -0.364 |
hsa-miR-744-3p | TIFAB | 9 cancers: BLCA; CESC; ESCA; HNSC; LUSC; OV; PAAD; SARC; THCA | mirMAP | TCGA BLCA -0.429; TCGA CESC -0.324; TCGA ESCA -0.255; TCGA HNSC -0.38; TCGA LUSC -0.23; TCGA OV -0.215; TCGA PAAD -0.343; TCGA SARC -0.519; TCGA THCA -0.798 |
hsa-miR-744-3p | CHURC1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; SARC; UCEC | mirMAP | TCGA BLCA -0.104; TCGA CESC -0.061; TCGA COAD -0.067; TCGA ESCA -0.109; TCGA HNSC -0.059; TCGA LIHC -0.054; TCGA LUAD -0.067; TCGA LUSC -0.155; TCGA SARC -0.141; TCGA UCEC -0.14 |
hsa-miR-744-3p | RORA | 11 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.209; TCGA COAD -0.335; TCGA ESCA -0.154; TCGA HNSC -0.086; TCGA LIHC -0.15; TCGA LUAD -0.18; TCGA LUSC -0.135; TCGA OV -0.099; TCGA PRAD -0.068; TCGA STAD -0.3; TCGA UCEC -0.234 |
hsa-miR-744-3p | ARHGEF9 | 12 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.096; TCGA CESC -0.161; TCGA ESCA -0.273; TCGA HNSC -0.085; TCGA LIHC -0.088; TCGA LUAD -0.082; TCGA LUSC -0.169; TCGA OV -0.053; TCGA PRAD -0.061; TCGA SARC -0.135; TCGA STAD -0.146; TCGA UCEC -0.095 |
hsa-miR-744-3p | CNTN4 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.416; TCGA CESC -0.315; TCGA COAD -0.533; TCGA ESCA -0.716; TCGA HNSC -0.29; TCGA LUAD -0.233; TCGA LUSC -0.31; TCGA PRAD -0.216; TCGA SARC -0.323; TCGA STAD -0.362; TCGA UCEC -0.498 |
hsa-miR-744-3p | KCNMA1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.67; TCGA BRCA -0.118; TCGA COAD -0.869; TCGA ESCA -0.422; TCGA HNSC -0.241; TCGA LUSC -0.245; TCGA OV -0.116; TCGA PRAD -0.379; TCGA SARC -0.506; TCGA THCA -0.4; TCGA STAD -0.79; TCGA UCEC -0.435 |
hsa-miR-744-3p | ARHGAP23 | 9 cancers: BRCA; CESC; COAD; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.086; TCGA CESC -0.145; TCGA COAD -0.189; TCGA LIHC -0.123; TCGA LUAD -0.131; TCGA PAAD -0.204; TCGA PRAD -0.476; TCGA STAD -0.193; TCGA UCEC -0.255 |
hsa-miR-744-3p | GPD1L | 10 cancers: BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.064; TCGA CESC -0.117; TCGA ESCA -0.255; TCGA HNSC -0.217; TCGA LUAD -0.174; TCGA LUSC -0.23; TCGA PRAD -0.16; TCGA SARC -0.234; TCGA STAD -0.063; TCGA UCEC -0.107 |
Enriched cancer pathways of putative targets